BioSyent, Inc. (TSXV: RX / OTC: BIOYF) is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients. BioSyent supports the healthcare professionals that treat these patients by marketing its products through its community, specialty and international business units.

This Company Webcast was recorded during the Lytham Partners Fall 2024 Investor Conference.